This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Luis Llamas
Introduction
Luis Llamas is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. His work focuses on the modulation of the hedgehog signaling pathway, which is crucial in various pathologies.
Latest Patents
Luis Llamas holds a patent for "Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway." This patent relates to compounds that are instrumental in the diagnosis and treatment of conditions associated with the Hedgehog pathway, including tumor formation, cancer, neoplasia, and non-malignant hyperproliferative disorders. He has 1 patent to his name.
Career Highlights
Luis Llamas is currently employed at Novartis AG, a leading global healthcare company. His role involves extensive research and development aimed at creating innovative solutions for complex medical challenges. His expertise in the hedgehog signaling pathway has positioned him as a key player in the fight against cancer.
Collaborations
Luis has collaborated with notable colleagues, including Miao Dai and Feng He. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Luis Llamas exemplifies the spirit of innovation in the biomedical field. His contributions to cancer research through his patented work are paving the way for new therapeutic strategies.